Skip to main content
. Author manuscript; available in PMC: 2017 Jun 30.
Published in final edited form as: Psychiatry Res. 2016 Apr 23;240:278–283. doi: 10.1016/j.psychres.2016.04.078

Table 1.

Demographic information, clinical features and medications for manic bipolar disorder (BD) subjects and healthy comparison subjects (HCS).

BD patients HCS Group differences
Gender 26M, 24F 15M, 24F ns
Age (years) 34.2 (12.7) 29.6 (10.7) ns
Years of education 13.8 (2.1) 15.0 (1.6) t (87) = 3.01, p = .003
Body Mass Index 27.4 (7.4)a 25.0 (5.0) ns
Clinical features
    Age of onset of illness 22.7 (8.4)b - -
    Duration of illness (years) 11.1 (10.0)b - -
    Number of days in treatment 5.02 (4.96) - -
    YMRS total score 26.0 (10.3) - -
    BPRS total score 37.0 (12.9) - -
Medication at time of testing
    Antipsychotic alone n = 12 (24%) - -
    Mood stabilizer alone n = 4 (8%) - -
    Antipsychotic plus mood stabilizer n = 32 (64.0%) - -
Not medicated n = 2 (4%) - -
Additional Medications
    Benzodiazepine n = 24 (48%) - -
    Antidepressant n = 1 (2%) - -

For all variables except gender and medications at time of testing values in the first column represent means and standard deviations.

BD = Bipolar Disorder, HCS = healthy comparison subject, M = male, F = female, ns = not significant, YMRS = Young Mania Rating Scale, BPRS = Brief Psychiatric Rating Scale.

a

Weight and height data were not available for two patients.

b

Age of onset and duration of illness could not be determined for three patients due to disorganized symptoms at the time of testing.